<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-87501</identifier>
<setSpec>0210-573X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Universal implementation of the &#147;Consecutive Combined Test&#148; in the South Seville area (Valme University Hospital)</dc:title>
<dc:description xml:lang="en">Universal application should be an aim in chromosomal abnormality screening, in addition to achieving adequate sensitivity and an acceptable false positive rate of the screening method applied. Objectives We aimed to implement universal chromosomal abnormality screening (coverage greater than 90% of pregnancies) in the southern area of Seville and to maintain the rate of diagnosis at 80% and the false-positive rate at 5%.MethodBetween July 2005 and September 2008, chromosomal abnormality screening through the consecutive combined test was offered to pregnant women in the southern area of Seville. The Double Test was used in women accessing screening later than 13 weeks of pregnancy. Results Of 12,478 pregnant women, chromosomal abnormality screening was offered to 95.1%. The consecutive combined test was performed in 86.86% of the pregnancies and screening was rejected by 6.32% of patients. Thirty-five chromosomal abnormalities were detected (a prevalence of 0.28%), of which 31 (88.5%) were diagnosed prenatally. The false-positive rate was 4.31%.ConclusionsUniversal application should be an objective of chromosomal abnormality screening, in addition to achieving adequate sensitivity and an acceptable false-positive rate in the screening method applied (AU)</dc:description>
<dc:creator>Turmo, E</dc:creator>
<dc:creator>Caballero, V</dc:creator>
<dc:creator>Peral, I</dc:creator>
<dc:creator>Serrano, R</dc:creator>
<dc:creator>Garrido, R</dc:creator>
<dc:creator>Sainz, J. A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La universalización debe ser un objetivo en el cribado de cromosomopatía además de lograr una adecuada sensibilidad y una tasa de falsos positivos (F+) del método de cribado aplicado. Objetivos Nos proponemos implementar un cribado de cromosomopatías en el área sur de Sevilla con la característica de universal (cobertura mayor del 90%) y manteniendo la tasa de diagnóstico del 80% para un 5% de F+. Método A nuestras gestantes, entre julio de 2005 y septiembre de 2008, se les oferta un test combinado consecutivo. En los casos de edad gestacional &gt;13 semanas se les aplica un doble test. Resultados Al 95,1%, de las 12.478 gestantes se les oferta un cribado. Al 86,85% de las gestantes se les realiza un test combinado consecutivo y el 6,43% de las gestantes han revocado el cribado. Se han observado 35 cromosomopatías (prevalencia de 0,28%), con una tasa de diagnóstico del 88,5% para un 4,31% de F+. Conclusiones La universalización debe ser un objetivo en el cribado de cromosomopatías además de lograr una adecuada sensibilidad y tasa de F+ (AU)</dc:description>
<dc:source>Clín. investig. ginecol. obstet. (Ed. impr.);37(4): 152-157, ago. 2010. ilus, tab</dc:source>
<dc:identifier>ibc-87501</dc:identifier>
<dc:title xml:lang="es">Implementación universal del «consecutive combined test» en el área sur de Sevilla (Hospital Universitario Valme)</dc:title>
<dc:subject>^d22261</dc:subject>
<dc:subject>^d13411</dc:subject>
<dc:subject>^d11732</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28087</dc:subject>
<dc:subject>^d29310</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d34293^s22016</dc:subject>
<dc:type>article</dc:type>
<dc:date>201008</dc:date>
</metadata>
</record>
</ibecs-document>
